Skip to main content

Table 2 Average daily doses of everolimus (mg/day) and mycophenolate mofetil (g/day) by visit window (safety population)

From: Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results

  Everolimus 1.5 mg (n= 61) MMF (n= 61)
Visit window n Mean ± SD n Mean ± SD
Day 3 61 1.49 (0.0.048) 61 1.95 (0.194)
Day 7 60 1.70 (0.447) 61 1.88 (0.297)
Month 1 57 1.72 (0.539) 60 1.70 (0.475)
Month 3 55 1.70 (0.628) 58 1.33 (0.606)
Month 4 55 1.68 (0.611) 56 1.22 (0.595)
Month 6 55 1.65 (0.602) 55 1.28 (0.583)
Month 7 55 1.61 (0.610) 54 1.28 (0.570)
Month 9 54 1.68 (0.656) 54 1.25 (0.530)
Month 12 53 1.68 (0.705) 53 1.24 (0.530)
  1. MMF, mycophenolate mofetil; SD, standard deviation.